China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.86 -0.02 (-0.70%)
As of: Nov 11, 2026 · 11:56 AM EST

China SXT Pharmaceuticals (SXTC) Capital Expenditures (2017 - 2025)

Updated

China SXT Pharmaceuticals' Capital Expenditures was -$2,023 in FY2025 (year ended Mar 31, 2025), compared with -$7,063 in FY2024.

Analysis

China SXT Pharmaceuticals (SXTC) Capital Expenditures (2017 - 2025) Analysis & Trends

From FY2017 onward, China SXT Pharmaceuticals has reported Capital Expenditures for 9 fiscal years.

  • The FY2025 figure marks the highest annual Capital Expenditures since FY2020.
  • Per Business Quant data, Capital Expenditures in earlier fiscal years was -$7,063 in FY2024, -$70,684 in FY2023, -$60,932 in FY2022 and -$78,302 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Yr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.84 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 4.83 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.21 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.11 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.55 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.81 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.86 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 563.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.63 Bn
10 China SXT Pharmaceuticals 345.60 -85.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 2,023.00
Mar 31, 2024 7,063.00
Mar 31, 2022 1,558.00
Mar 31, 2021 14,742.00
Mar 31, 2020 406,658.00
Mar 31, 2019 598,806.00
Mar 31, 2018 1.03 Mn
Mar 31, 2017 179,176.00
API Access

China SXT Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures-annual&ticker=SXTC&period=max&api_key=YOUR_API_KEY